Archives

by in
Entry Author Date Location
Arrowhead, Despite Ailing Stock, Reloads in RNAi Hepatitis B Fight 12/19/14 Wisconsin
Xconomy Boston’s Top Stories of Q3 2014: Editor’s Picks 10/01/14 Boston
Juan Enriquez, Mark Levin, Phil Sharp to Speak at Healthcare Summit Oct. 15 09/10/13 Boston
Alnylam Shares Boom on Early Data For Subcutaneous RNA Drug 07/11/13 Boston
Alnylam’s Amyloidosis Drug Holds up in Second Clinical Trial 07/01/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Alnylam Inks $29M Deal With Monsanto for New Bio Tools for Farmers 08/28/12 Boston
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi 07/27/11 Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence 05/26/11 Boston
Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters 05/26/11 Boston
David Cancel, Stephen Kaufer, Katie Rae, and Others Join XSITE Program on June 16 04/28/11 Boston
What do Desh Deshpande, Gilt Groupe, Nobelist Phil Sharp, & Intellectual Ventures Have in Common? All Are Keynoting at XSITE 2011-The Entrepreneurship Era 04/20/11 Boston
Alnylam Named in Complaint Over RNAi Patents 03/23/11 Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News 03/18/11 Boston
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO 03/24/10 Boston
Navinet and Vitality use Internet for Health, Constellation Gets to Series A, and Other Boston-Area Life Sciences News 08/19/09 Boston
Next 10 to Sign Up for XSITE 2009 are Eligible to Win a Garmin GPS System—So Hurry Up and Navigate to the Registration Site 06/09/09 Boston
The Health 2.0 Hub, Boston’s Secret Entertainment Cluster, A Path to Market for Energy Innovations, Dean Kamen, and more XSITEment 06/02/09 Boston
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Alnylam, Cubist Will Cooperate on RNAi Drug for Lung Infections 01/09/09 Boston
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News 12/24/08 Boston
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News 10/08/08 Boston
Alnylam Hires Chief Scientist, Jack Schmidt, To Help Build RNAi Pipeline 10/01/08 Boston
Alnylam, RXi On Collision Course Over Intellectual Property From Massachusetts Life Sciences Initiative 09/19/08 Boston
Alnylam Sees Opportunity in Turning Genes On, And Off 09/05/08 Boston
Alnylam’s In the Money: Expects $500 Million in Bank at Year-End 08/06/08 Boston
Alnylam’s Ebola Work Gets $7.5 Million Commitment 08/06/08 Boston
Alnylam Obtains Intellectual Property For RNA Activation, Turning Genes On Instead of Off 08/04/08 Boston
Page 1 of 2 next page »